Investor appetites in question regarding alternative proteins
The alternative protein industry—referring to food, drinks, or ingredients made with non-animal sources of protein—has experienced explosive growth over the past decade. However, the industry has struggled recently to maintain momentum and faces pressure in the current inflationary environment.
Alt-protein startups collected $883.8 million across 57 deals in Q1 2022. However, quarterly deal values are down 62.6% from the peak in Q3 2021.
Our latest Emerging Tech Research analyst note explores the rise of cultivated protein along with opportunities in sectors including alternative fat and alternative seafood in the face of shifting market conditions. The report includes key VC deals and company spotlights on Meati Foods and BlueNalu.
Table of contents
| Key takeaways | 1 |
| The state of alternative protein | 2 |
| The rise of cultivated protein | 3 |
| Emerging opportunities: Alternative fat | 5 |
| Emerging opportunities: Alternative seafood | 7 |
| Select company highlights: Meati Foods | 9 |
| Select company highlights: BlueNalu | 10 |
| H1 2022 timeline | 11 |
| Alt-protein VC ecosystem market map & definitions | 13 |
| VC activity and deal trends | 14 |